Organization | Arla Foods

Arla Foods Report issue

For profit Phase 2 Phase 4

Founded: Viby Denmark (2000)

Status: No NME R&D (2000)

Organization Overview

First Clinical Trial

2008

NCT00809874

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

Arla Food for Health | Arla Food Ingrediens | Arla Food Ingredients | Arla Food Ingredients Group P/S | Arla food ingredients group R&D | Arla Foods | Arla Foods Ingredients

Active Ingredients

Drugs in Phase 4 Trials (1)

whey protein (11 trials)

Drugs in Phase 2 Trials (1)

alpha-lactalbumin (3 trials)

Drugs in Other Trials (21)

beta-hydroxybutyrate (1 trial)

calcium (1 trial)

calcium alginate (1 trial)

calcium carbonate (1 trial)

casein (1 trial)

cow milk (3 trials)

flax seed fibres (1 trial)

hydrolysed whey protein (2 trials)

hydrolyzed casein (1 trial)

ketone (2 trials)

lactobacillus paracasei (1 trial)

maltodextrin (2 trials)

medium-chain saturated fatty acids (1 trial)

mesalamine (rowasa) (1 trial)

milk protein (7 trials)

multivitamins (1 trial)

probiotic (1 trial)

vitamin d (1 trial)

vitamin d3 (1 trial)

whey (4 trials)

yogurt bacteria (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Malnutrition (Phase 4)

Tuberculosis (Phase 4)

Tuberculosis, Pulmonary (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 27
# of Trial APIs: 23